Blackstone Life Sciences

A private, global investment platform focused on the life sciences sector.

Venture Capital New York, United States Est. 2018
Visit website ↗
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
Late-Stage

About

Blackstone Life Sciences (BXLS) is a private investment platform that invests across the life cycle of companies and products within the key life science sectors. It aims to bring innovative medicines and medical technologies to market by providing financing, operational support, and strategic partnerships. BXLS combines clinical, commercial, and operational expertise with Blackstone's global network and capital to advance promising life science products and companies.

Portfolio

No portfolio companies in this dataset yet.

Q&A

What is Blackstone Life Sciences' primary investment focus?
Blackstone Life Sciences is a private investment platform focused on funding the late-stage development of innovative medicines and medical technologies within the life sciences sector.
What is the total AUM for Blackstone Life Sciences?
Blackstone Life Sciences has a total Assets Under Management (AUM) of $15 billion.
What is Blackstone Life Sciences' investment thesis?
Blackstone Life Sciences funds products, not companies, focusing on late-stage development of innovative core products from highly credible counterparties to deliver attractive, market-uncorrelated returns at lower risk.
What is the typical check size for Blackstone Life Sciences' investments?
Blackstone Life Sciences typically invests a minimum of $150 million per deal.
When was Blackstone Life Sciences founded?
Blackstone Life Sciences was founded in 2018.
What are the preferred investment stages for Blackstone Life Sciences?
Blackstone Life Sciences primarily focuses on Late-Stage investments.
Which funds has Blackstone Life Sciences raised?
Blackstone Life Sciences raised Blackstone Life Sciences V in 2020 with $4.6 billion and Blackstone Life Sciences VI in 2026 with $6.3 billion.
Who leads Blackstone Life Sciences?
Nicholas Galakatos serves as the Global Head of Blackstone Life Sciences.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)